94 related articles for article (PubMed ID: 1779306)
1. A molecular modeling approach to in vivo efficacy of triclabendazole.
Lipkowitz KB; McCracken RO
J Parasitol; 1991 Dec; 77(6):998-1005. PubMed ID: 1779306
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling of rat liver mitochondrial oxidative phosphorylation by the fasciolicide triclabendazole and its sulfoxide and sulfone metabolites.
Carr AW; McCracken RO; Stillwell WH
J Parasitol; 1993 Apr; 79(2):198-204. PubMed ID: 8459330
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of benzothiazole and benzimidazole anthelmintics: a molecular modeling approach to in vivo drug efficacy.
McCracken RO; Lipkowitz KB
J Parasitol; 1990 Dec; 76(6):853-64. PubMed ID: 2254820
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro cysticidal activity of new benzimidazole derivatives.
Palomares-Alonso F; Jung-Cook H; Pérez-Villanueva J; Piliado JC; Rodríguez-Morales S; Palencia-Hernández G; López-Balbiaux N; Hernández-Campos A; Castillo R; Hernández-Luis F
Eur J Med Chem; 2009 Apr; 44(4):1794-800. PubMed ID: 18582991
[TBL] [Abstract][Full Text] [Related]
5. Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation.
Mottier L; Moreno L; Alvarez L; Virkel G; Lanusse C
J Pharm Biomed Anal; 2004 Sep; 35(5):991-9. PubMed ID: 15336346
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutic evaluation of novel anthelmintic (1H-benzimidazol-5(6)-yl)carboxamide derivatives.
Rivera JC; Yépez-Mulia L; Hernández-Campos A; Moreno-Esparza R; Castillo R; Navarrete-Vázquez G; Fuentes-Noriega I; Jung-Cook H
Int J Pharm; 2007 Oct; 343(1-2):159-65. PubMed ID: 17624700
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling: a tool for predicting anthelmintic activity in vivo.
Lipkowitz KB; McCracken RO
Parasitol Res; 1993; 79(6):475-9. PubMed ID: 8415561
[TBL] [Abstract][Full Text] [Related]
8. Experimental and theoretical studies of albendazole, oxibendazole, and tioxidazole.
McCracken RO; Lipkowitz KB
J Parasitol; 1990 Apr; 76(2):180-5. PubMed ID: 2319417
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic interaction between oxfendazole and triclabendazole: In vitro biotransformation and systemic exposure in sheep.
Viviani P; Lifschitz AL; Luque SE; Lloberas MM; Maté ML; Cardozo PA; Lanusse CE; Virkel GL
Exp Parasitol; 2019 Sep; 204():107718. PubMed ID: 31201779
[TBL] [Abstract][Full Text] [Related]
10. A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement.
Robinson MW; McFerran N; Trudgett A; Hoey L; Fairweather I
J Mol Graph Model; 2004 Dec; 23(3):275-84. PubMed ID: 15530823
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting pharmacokinetics of benzimidazole anthelmintics in food-producing animals: the consequences and potential risks.
Křížová-Forstová V; Lamka J; Cvilink V; Hanušová V; Skálová L
Res Vet Sci; 2011 Dec; 91(3):333-41. PubMed ID: 21310449
[TBL] [Abstract][Full Text] [Related]
12. 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors.
Alpan AS; Gunes HS; Topcu Z
Acta Biochim Pol; 2007; 54(3):561-5. PubMed ID: 17823665
[TBL] [Abstract][Full Text] [Related]
13. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
[TBL] [Abstract][Full Text] [Related]
14. Relationships between the anthelmintic activity of eight derivatives of benzimidazole carbamates against Trichinella spiralis and their chemical structures.
Latif LA; Surin J
Jpn J Med Sci Biol; 1993; 46(5-6):203-14. PubMed ID: 8051807
[TBL] [Abstract][Full Text] [Related]
15. Piperazine derivatives of benzimidazole as potential anthelmintics. Part 1: Synthesis and activity of methyl-5-(4-substituted piperazin-1-yl)benzimidazole-2-carbamates.
Sánchez-Alonso RM; Raviña E; Santana L; García-Mera G; Sanmartín M; Baltar P
Pharmazie; 1989 Sep; 44(9):606-7. PubMed ID: 2608706
[TBL] [Abstract][Full Text] [Related]
16. Chromophore/DNA interactions: femto- to nanosecond spectroscopy, NMR structure, and electron transfer theory.
von Feilitzsch T; Tuma J; Neubauer H; Verdier L; Haselsberger R; Feick R; Gurzadyan G; Voityuk AA; Griesinger C; Michel-Beyerle ME
J Phys Chem B; 2008 Jan; 112(3):973-89. PubMed ID: 18163608
[TBL] [Abstract][Full Text] [Related]
17. Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives.
Mavrova ATs; Anichina KK; Vuchev DI; Tsenov JA; Denkova PS; Kondeva MS; Micheva MK
Eur J Med Chem; 2006 Dec; 41(12):1412-20. PubMed ID: 16996654
[TBL] [Abstract][Full Text] [Related]
18. [Comparative pharmacokinetics of triclabendazole in camels and sheep].
Oukessou M; Toutain PL; Galtier P; Alvinerie M
Rev Elev Med Vet Pays Trop; 1991; 44(4):447-52. PubMed ID: 1843827
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.
Mestorino N; Formentini EA; Lucas MF; Fernandez C; Modamio P; Hernández EM; Errecalde JO
Vet Res Commun; 2008 Jan; 32(1):21-33. PubMed ID: 17457687
[TBL] [Abstract][Full Text] [Related]
20. Rotamerism, tautomerism, and excited-state intramolecular proton transfer in 2-(4'-N,N-diethylamino-2'-hydroxyphenyl)benzimidazoles: novel benzimidazoles undergoing excited-state intramolecular coupled proton and charge transfer.
Vazquez SR; Rodríguez MC; Mosquera M; Rodríguez-Prieto F
J Phys Chem A; 2008 Jan; 112(3):376-87. PubMed ID: 18154323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
